Profile data is unavailable for this security.
About the company
PharmaCielo Ltd. is a Canada-based global company with a focus on ethical and sustainable cultivation, processing and supplying of all natural, pharmaceutical-grade medical dried cannabis flower and cannabis products to large channel distributors. The Company has two subsidiaries, PharmaCielo Colombia Holdings S.A.S. (PharmaCielo Colombia) and Ubiquo Telemedicina S.A.S. (Ubiquo). PharmaCielo Colombia cultivates and processes the Company’s all-natural cannabis into standardized, medicinal-grade dried cannabis flower, cannabis oil extracts and cannabis-related products sold in bulk to pharmaceutical companies and medicinal cannabis distributors globally. In Colombia, PharmaCielo Colombia is a fully licensed cultivator, producer, and distributor of both TetraHydroCannabinol and Cannabidiol medical cannabis. Ubiquo is a knowledge management and medical consultation system. Ubiquo is a technology platform and a user interface that allows doctors and patients to communicate.
- Revenue in CAD (TTM)2.83m
- Net income in CAD-6.42m
- Incorporated2017
- Employees268.00
- LocationPharmacielo Ltd82 Richmond Street EastTORONTO M5C 1P1CanadaCAN
- Phone+1 (416) 315-8741
- Fax+1 (416) 315-8741
- Websitehttps://www.pharmacielo.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kane Biotech Inc | 574.87k | -1.95m | 7.26m | -- | -- | -- | -- | 12.64 | -0.0114 | -0.0214 | 0.0034 | -0.0047 | 0.173 | 1.30 | 2.42 | -- | -58.59 | -80.66 | -192.03 | -- | -16.60 | 44.47 | -338.70 | -257.96 | 0.7172 | -10.81 | 1.53 | -- | 1,296.75 | 4.21 | 30.71 | -- | -1.53 | -- |
| Cytophage Technologies Ltd | 0.00 | -4.57m | 11.17m | -- | -- | 8.72 | -- | -- | -0.0816 | -0.0816 | 0.00 | 0.0189 | 0.00 | -- | -- | -- | -98.03 | -- | -117.55 | -- | -- | -- | -- | -- | -- | -59.47 | 0.5422 | -- | -- | -- | -69.62 | -- | -- | -- |
| Pharmacielo Ltd | 2.83m | -6.42m | 13.15m | 268.00 | -- | -- | -- | 4.66 | -0.0356 | -0.0356 | 0.0156 | -0.0795 | 0.1994 | 1.71 | 4.10 | -- | -45.28 | -- | -- | -- | 3.13 | -- | -227.15 | -- | 0.0907 | -3.01 | 6.18 | -- | -- | -- | -- | -- | -- | -- |
| Simply Solventless Concentrates Ltd | 30.71m | 4.17m | 17.90m | 192.00 | 8.79 | 0.5605 | 3.07 | 0.583 | 0.0176 | 0.0176 | 0.2643 | 0.2765 | 0.725 | 1.11 | 7.89 | 159,949.40 | 9.84 | -- | 13.15 | -- | 28.99 | -- | 13.57 | -- | 0.7405 | -0.5981 | 0.3241 | -- | 120.93 | -- | -599.34 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| AdvisorShares Investments LLCas of 31 Dec 2025 | 333.62k | 0.18% |
